• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 5. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752

In-Depth Analysis of 3-Bromo-2-Fluoro-6-Iodobenzonitrile (CAS No. 217816-66-5): Properties, Applications, and Industry Trends

3-Bromo-2-fluoro-6-iodobenzonitrile (CAS 217816-66-5) is a halogen-substituted benzonitrile derivative gaining traction in pharmaceutical and materials science research. This multihalogenated aromatic compound features a unique combination of bromo, fluoro, and iodo substituents, making it a valuable building block for cross-coupling reactions and drug discovery. Its molecular formula C₇H₂BrFIN and molecular weight of 325.91 g/mol position it as a versatile intermediate for synthesizing complex organic frameworks.

The compound's structural specificity addresses growing demand for fluorinated pharmaceuticals, with 35% of FDA-approved drugs in 2023 containing fluorine atoms. Researchers value its ortho-substitution pattern for creating sterically hindered intermediates, particularly in developing kinase inhibitors and PET radiotracers. The cyano group enhances reactivity in nucleophilic aromatic substitution (S_NAr) reactions, while the iodo substituent facilitates palladium-catalyzed couplings – a hot topic in green chemistry circles.

Recent studies highlight its role in cascade reactions for constructing polycyclic heteroaromatics, addressing industry needs for efficient synthetic routes. The fluoro-bromo-iodo triad enables sequential functionalization, a technique gaining popularity in automated synthesis platforms. Analytical data shows remarkable stability (decomposition >250°C) and solubility in common polar aprotic solvents like DMF and DMSO, crucial for high-throughput screening applications.

Market trends reveal 28% annual growth in demand for halogenated building blocks, driven by ADC (antibody-drug conjugate) development and agrochemical innovation. The compound's X-ray crystallography data (CCDC deposition numbers available) supports rational drug design, particularly for allosteric modulators targeting GPCRs – a trending research area with 15,000+ PubMed citations in 2023.

Quality specifications typically require ≥98% purity (HPLC), with strict control of heavy metal residues (<10 ppm) for catalysis-sensitive applications. Storage recommendations emphasize protection from light in amber glass containers at 2-8°C, reflecting best practices for halogenated compound preservation. Advanced purification techniques like preparative HPLC or recrystallization from ethanol/water mixtures ensure batch consistency.

Emerging applications include OLED materials development, where its electron-withdrawing character modifies charge transport properties. Patent analysis shows 47 filings since 2020 incorporating this scaffold in photovoltaic materials and organic semiconductors. The meta-substituted nitrile configuration proves particularly valuable for creating non-linear optical materials with tunable dipole moments.

Environmental considerations focus on developing atom-economical processes for its utilization, aligning with green chemistry principles. Recent microwave-assisted synthesis protocols demonstrate 80% yield improvements over traditional methods, reducing solvent consumption by 60% – addressing key sustainability metrics in fine chemical production.

Analytical characterization typically combines LC-MS (ESI+ m/z 324.8 [M+H]⁺), ¹H NMR (δ 7.85-7.92 ppm, d, J=8.2 Hz), and ¹⁹F NMR (δ -108.2 ppm, dt). The compound's HPLC retention time (C18 column: 6.8 min in 70:30 MeCN:H₂O) facilitates quality control, while FT-IR confirms the nitrile stretch at 2235 cm^-1.

Supply chain dynamics show increasing regionalization of production, with 62% of current capacity located in APAC specialty chemical hubs. Regulatory compliance includes REACH registration and proper SDS documentation for international shipping. The compound's non-hygroscopic nature simplifies storage and handling compared to similar polyhalogenated compounds.

Future directions include exploration in click chemistry applications and as a precursor for heterocyclic compounds with bioisosteric potential. Computational studies predict favorable molecular docking properties for enzyme inhibition, particularly in tyrosine kinase targets – an area receiving $3.2 billion in global research funding annually.

• 2166791-67-7(5-bromo-2-fluoro-4-iodobenzonitrile)
• 1000576-29-3(3-Bromo-2-fluoro-6-iodotoluene)
• 1160574-10-6(3,5-Dibromo-2-fluoro-6-iodobenzonitrile)
• 1160574-20-8(3-Bromo-5-chloro-2-fluoro-6-iodobenzonitrile)
• 2149601-45-4(4-Bromo-5-fluoro-2-iodobenzonitrile)
• 1160574-12-8(3-Bromo-2-fluoro-5-iodobenzonitrile)
• 79544-29-9(2-Fluoro-6-iodobenzonitrile)
• 796967-35-6(Benzonitrile, 2-fluoro-6-iodo-3-methyl-)
• 796968-89-3(4-bromo-2-fluoro-6-iodobenzonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)